Home / HIPRA BIOTECH SERVICES | Aiguaviva /

HIPRA BIOTECH SERVICES | Aiguaviva

End-to-end internal capabilities from cell line development to commercial manufacturing.

Spain Europe

HIPRA BIOTECH SERVICES | Aiguaviva

End-to-end internal capabilities from cell line development to commercial manufacturing.

HIPRA BIOTECH SERVICES | Aiguaviva
HIPRA BIOTECH SERVICES | Aiguaviva
HIPRA BIOTECH SERVICES | Aiguaviva
HIPRA BIOTECH SERVICES | Aiguaviva
HIPRA BIOTECH SERVICES | Aiguaviva
HIPRA BIOTECH SERVICES | Aiguaviva
HIPRA BIOTECH SERVICES | Aiguaviva
HIPRA BIOTECH SERVICES | Aiguaviva
HIPRA BIOTECH SERVICES | Aiguaviva

About the plant

HIPRA Biotech Services is HIPRA’s CDMO division, bringing over 50 years of scientific and technical excellence to pharmaceutical and biotechnology companies, offering comprehensive contract development and manufacturing services in a wide range of biologics technologies and modalities.

  • We have capacity available now to start development, clinical supply and commercial manufacturing projects in mammalian, microbial, and aseptic fill & finish.
  • We are able to hit as demonstrated by BIMERVAX® (which we adapt each year in 4-6 months) and our typical lead times demonstrated in dozens of programs in Animal Health
  • We have been EMA approved for almost 30 years with an excellent inspection track record, and we are getting ready for FDA approval by mid-2026

 

Our AMER campus offers DS and DP Manufacturing and QC services, while our AIGUAVIVA campus contains our R&D facilities as well as our DS Manufacturing expansion.

 

DEVELOPMENT SERVICES (AIGUAVIVA CAMPUS)

From early discovery to clinical manufacturing production, we accelerate each stage of biologics drug development with expertise and flexibility.

Our AIGUAVIVA Development labs feature high-throughput bioreactor systems (Ambr®15 and Ambr®250) for design of experiments, small- and mid-scale benchtop bioreactors, Cobas® analyzers (for clinical chemistry and immunochemistry assays), and advanced tools for cell line development, complemented by a specialized area for process development and a dedicated GMP area for early-phase clinical batch production.

 

MANUFACTURING AND QC SERVICES (AMER AND AIGUAVIVA CAMPUSES)

We provide robust and flexible pharmaceutical manufacturing and quality control services at our state-of-the-art GMP certified facilities.

Our AMER DS facilities feature top-of-the-line single-use 500L cell culture bioreactors, 2000L microbial fermentation single-use bioreactors and stainless-steel fermenters, single-use chromatography, tangential flow filtration, and centrifuges.

Our AIGUAVIVA DS facilities feature top-of-the-line 2000L microbial fermentation single-use bioreactors and stainless-steel fermenters, single-use chromatography, tangential flow filtration, and centrifuges.

Our AMER DP facility features a high-speed isolator liquid vial filling line with 100% IPC.

Our AMER QC labs feature a wide variety of equipment enabling a wide range of methods; equipment is the same as used in the Analytical Methods development lab.


Certifications
  • EMA (EU GMP)
  • World Health Organization (GMP / HACCP)

Activity
  • Abs (Antibodies), Peptide, protein, hormone & enzyme, Oligonucleotides, Vaccines, BIOLOGICS manufacturing

Features
  • Uses: Investigational, Commercial (Phase IV), Preclinical, Phase I, Phase II, Phase III, Human, Veterinary
  • Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1,000 - 5,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)
  • DEA: N/A
  • BSL: 1, 2, 3
  • Therapeutic areas: N/A
  • Markets: EMA (EU)

Batch Size / Reactor
  • Small, Medium, Large, Batch, Fed-batch, 1 - 100 L, 100 - 1000 L, 1000 - 2000 L

Services
  • Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging, Logistics, Preformulation studies, R&D, Formulation / Galenic design, Process development, Process optimization, Process validation, Stability studies design, Stability studies execution, ICH Stability studies, Downstream, Fill&Finish, Cell line development, Cell banking, Sterile product manufacturing, Non sterile product manufacturing, Upstream, Tech transfer, Pilot plant, Formulation mixing, Research batches, Engineering batches, Scale-up, Pilot batches, Registration batches, Batch records, Analytical methods development, Analytical methods validation, Release testing of raw materials, Release testing of product, Analytical methods transfer, QP in house, Batch certification / release, GMP documentation

Get in touch
Address: Carretera, GI-533, km 4 4, 17181 Aiguaviva, Girona
Spain
Year: 1971
Plant Documents
Other plants of this company
Contact the CDMO commercial and technical team directly

I have read and accept the Terms and Conditions and the Privacy Policy.

Contact us

If you have any questions or suggestions, click here. We will be happy to assist you.

Want to see all the information?

Unleash the full power of MAI CDMO

Register for free

FAES FARMA
Mabion
53Biologics
ChemCon
Salvat
Cambrex